Skip to main content
Full access
Letters
Published Online: 1 April 2012

Should We Consider the Depth of the Cortex for the Use of rTMS?

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Repetitive Transcranial Magnetic Stimulation (rTMS) is known to have therapeutic effects in Treatment Resistant Depression (TRD) when it is applied over the dorsolateral prefrontal cortex (DLPFC).1 However, its therapeutic effects remain modest and thus factors that attenuate the effects of rTMS in the brain should be identified. The depth of the cortex, which is never considered for the use of rTMS, might explain why rTMS therapy sometimes fails.

Case Report

A 43-year-old woman, suffering from TRD lasting for 10 years, was referred to our department for rTMS therapy. The patient presented a history of asymptomatic moderate prefrontal atrophy, confirmed by a recent neurological evaluation including neuropsychological tests that excluded fronto-temporal dementia.
We decided to deliver low- frequency (1 Hz) rTMS over the right DLPFC (360 pulses per session) using a Figure 8 coil. We used a 120% resting Motor Threshold (MT), one of the highest recommended intensities.1 MRI-based neuronavigation was used to localize the DLPFC. We assessed rTMS efficacy using the Hamilton and the Montgomery Asberg Depression Rating Scale (HDRS, MADRS).
The patient received 10 sessions over 2 weeks, but showed no significant improvement assessed by the two scales (HDRS: 35 to 32; MADRS: 34 to 33). Four weeks later, an additional 10 sessions were given over 2 weeks. Once again, the treatment proved to be ineffective (HDRS: 33 to 30; MADRS: 33 to 25). We decided to stop rTMS therapy after 6 additional sessions that also proved to be ineffective.

Discussion

rTMS therapy aims to induce depolarization of the cortex located just below the stimulation coil thanks to a magnetic field.2 The intensity of the stimulation to deliver to the DLPFC is determined by measuring the MT. The MT is defined by the electric charge required to induce a muscle response.1
But the distance from the scalp to the DLPFC may be greater than the distance from the scalp to the motor cortex as in the present case (Figure 1). Since the magnetic field decreases dramatically with distance from the source, we were unable to confirm that DLPFC neurons were activated in this case.3
FIGURE 1. Parasagittal MRI of the Right Cerebral Hemisphere: Difference Between the Depth of the Motor Cortex and the Dorsolateral Prefrontal Cortex
By way of illustration, we used an electric charge of 94 A/ms to stimulate the DLPFC (120% MT) in our patient, in whom the distance from the scalp to the motor cortex was 1.8 cm whereas that to the DLPFC was 2.2 cm. When we placed the coil over the motor cortex at a distance of 2.2 cm with electric charge at 94 A/ms, we found that we were unable to induce a motor response in the contralateral muscles. In fact, the electric charge required to reach the MT in our patient at this distance from the motor cortex was 125 A/ms. This value is so high that it was impossible to treat the patient using 120% MT, because it would have required 100.8% of the stimulator’s power.
Brain anatomy including variations in the depth of the cortex may be an important factor for the efficacy of TMS therapy.

References

1.
Rossi S, Hallett M, Rossini PM, et al.; Safety of TMS Consensus Group: Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120:2008–2039
2.
Daskalakis ZJ, Levinson AJ, Fitzgerald PB: Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry 2008; 53:555–566
3.
Zangen A, Roth Y, Voller B, et al.: Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005; 116:775–779

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E3 - E4
PubMed: 22772689

History

Published online: 1 April 2012
Published in print: Spring 2012

Authors

Details

Benoit Trojak, M.D.
-Department of Psychiatry and Addictology, University Hospital of Dijon, France
-EA 4452, Laboratory of Psychopathology and Medical Psychology, University of Burgundy, France
Vincent Meille, M.S.
-Department of Psychiatry and Addictology, University Hospital of Dijon, France
Olivier Rouaud, M.D.
-Department of Neurology, University Hospital of Dijon, France
Jean-Christophe Chauvet-Gelinier, M.D.
-Department of Psychiatry and Addictology, University Hospital of Dijon, France
-EA 4452, Laboratory of Psychopathology and Medical Psychology, University of Burgundy, France
Bernard Bonin, M.D., Ph.D.
-Department of Psychiatry and Addictology, University Hospital of Dijon, France

Notes

Corresponding author: Dr Benoit Trojak Department of Psychiatry and Addictology University Hospital of Dijon 21000 Dijon, France Tel: +33 3 80 29 37 69 Fax: +33 3 80 29 33 45 e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share